Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan
· Delayed Price · Currency is TWD 71.50
+1.20 (1.71%)
Apr 2, 2025, 1:30 PM CST
TPEX:4747 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 84.12 | 79.7 | 64.85 | 49.1 | 63.56 | Upgrade
|
| Depreciation & Amortization | 20.97 | 21.11 | 18.27 | 15.29 | 13.23 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.01 | - | 0.01 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.44 | -0.15 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 6.38 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -0.2 | 0.09 | 0.88 | - | -0.48 | Upgrade
|
| Other Operating Activities | -7.77 | 8.13 | 3.42 | 4.97 | -2.4 | Upgrade
|
| Change in Accounts Receivable | -2.2 | -4.87 | -23.76 | -2.49 | 14.62 | Upgrade
|
| Change in Inventory | -2.09 | -11.78 | 19.45 | 11.44 | -24.48 | Upgrade
|
| Change in Accounts Payable | -27.87 | 34.5 | -1.67 | -17.03 | 7.57 | Upgrade
|
| Change in Unearned Revenue | 0.52 | 0.29 | -1.33 | 3.51 | -2.47 | Upgrade
|
| Change in Other Net Operating Assets | -3.04 | 3.56 | 9.58 | -12.46 | 2.61 | Upgrade
|
| Operating Cash Flow | 62.88 | 136.95 | 89.69 | 52.35 | 71.77 | Upgrade
|
| Operating Cash Flow Growth | -54.09% | 52.70% | 71.33% | -27.07% | 0.36% | Upgrade
|
| Capital Expenditures | -13.19 | -33.12 | -59.71 | -37.29 | -162.18 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.01 | - | - | 0.63 | Upgrade
|
| Other Investing Activities | 0.24 | -0.17 | -0.21 | -0.86 | -0.06 | Upgrade
|
| Investing Cash Flow | -12.96 | -33.28 | -59.92 | -38.15 | -161.61 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 130 | Upgrade
|
| Long-Term Debt Issued | - | 395.36 | - | - | - | Upgrade
|
| Total Debt Issued | - | 395.36 | - | - | 130 | Upgrade
|
| Short-Term Debt Repaid | - | - | -20 | -50 | - | Upgrade
|
| Total Debt Repaid | - | - | -20 | -50 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 395.36 | -20 | -50 | 130 | Upgrade
|
| Issuance of Common Stock | - | 480 | - | - | - | Upgrade
|
| Common Dividends Paid | -67.32 | -60.04 | -43.53 | -57.64 | -54.03 | Upgrade
|
| Other Financing Activities | -0.15 | 0.15 | - | - | - | Upgrade
|
| Financing Cash Flow | -67.47 | 815.47 | -63.53 | -107.64 | 75.97 | Upgrade
|
| Net Cash Flow | -17.55 | 919.14 | -33.76 | -93.44 | -13.87 | Upgrade
|
| Free Cash Flow | 49.68 | 103.84 | 29.98 | 15.06 | -90.41 | Upgrade
|
| Free Cash Flow Growth | -52.15% | 246.36% | 99.09% | - | - | Upgrade
|
| Free Cash Flow Margin | 8.13% | 17.11% | 6.06% | 3.66% | -21.32% | Upgrade
|
| Free Cash Flow Per Share | 1.10 | 2.73 | 1.00 | 0.50 | -3.00 | Upgrade
|
| Cash Interest Paid | - | 1.42 | 1.06 | 1.2 | 0.67 | Upgrade
|
| Cash Income Tax Paid | - | 16.23 | 13.27 | 7.74 | 15.54 | Upgrade
|
| Levered Free Cash Flow | 22.48 | 80.62 | 15.88 | 9.92 | -106.25 | Upgrade
|
| Unlevered Free Cash Flow | 24.67 | 83.49 | 16.54 | 10.59 | -105.75 | Upgrade
|
| Change in Net Working Capital | 44.49 | -27.35 | -6.86 | 6.34 | 4.31 | Upgrade
|
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.